Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |